Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label, single center, single-dose study to assess the effects of age, weight, and body composition on the pharmacokinetic profile, safety, and tolerability of intravenous diclofenac sodium (DIC075V) in adult volunteers

Trial Profile

An open-label, single center, single-dose study to assess the effects of age, weight, and body composition on the pharmacokinetic profile, safety, and tolerability of intravenous diclofenac sodium (DIC075V) in adult volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Javelin Pharmaceuticals

Most Recent Events

  • 11 Feb 2009 Additional lead investigator identified as reported by ClinicalTrials.gov, last updated 11-2-2009.
  • 11 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 11 Feb 2009 Actual end date changed from (Mar 2008) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top